European biotech alliance to combat global health threat
Biotech companies from 10 different EU countries have teamed up in a new alliance to develop antibiotics targeting multiresistant bacteria.
BY KASPER HEIDE LUND
Multiresistant bacteria are broadly viewed as a global health threat and the problem is responsible for about 50,000 deaths in Europe and the US alone each year.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
Massive surge in multiresistant bacteria
For abonnenter
Bacteria mapping might replace antibiotics
For abonnenter
85 million to save humanity
For abonnenter
